Evidence map›Paper›PMID 37112660›Full record

ArticleVaccines2023

Burden of Acute-Care Hospitalization for Community-Acquired Pneumonia in Canadian Adults Aged 50 Years or Older: Focusing on Most Responsible Diagnosis Tells Only Part of the Story.

Ana Gabriela Grajales Beltrán, Derek Lytle, Jelena Vojicic, Prerna Grover, Lidija Latifovic, Shane Golden, Juejing Ling, Brad Millson, Alejandro Cane

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ana Gabriela Grajales BeltránVaccines Medical Affairs, Pfizer Canada, Kirkland, QC H9J 2M5, Canada.
Derek LytleMarket Access, Pfizer Canada, Kirkland, QC H9J 2M5, Canada.ORCID 0009-0005-7332-5644
Jelena VojicicVaccines Medical Affairs, Pfizer Canada, Kirkland, QC H9J 2M5, Canada.
Prerna GroverReal-World Solutions, IQVIA Canada, Mississauga, ON L5N 6A4, Canada.
Lidija LatifovicReal-World Solutions, IQVIA Canada, Mississauga, ON L5N 6A4, Canada.
Shane GoldenReal-World Solutions, IQVIA Canada, Mississauga, ON L5N 6A4, Canada.
Juejing LingReal-World Solutions, IQVIA Canada, Mississauga, ON L5N 6A4, Canada.
Brad MillsonReal-World Solutions, IQVIA Canada, Mississauga, ON L5N 6A4, Canada.
Alejandro CaneVaccines Medical and Scientific Affairs, North America, Pfizer Inc., Collegeville, PA 19426, USA.
Pfizer (Canada) · CAPfizer (United States) · US

Funding

Pfizer (Canada) N/A
6 · The paper itself

Abstract

The burden of all-cause community-acquired pneumonia (CAP), including pneumococcal pneumonia, is typically estimated using ICD codes where pneumonia is coded as the most responsible diagnosis (MRDx). Pneumonia may also be coded as other than most responsible diagnosis (ODx) based on administrative and reimbursement criteria. Analyses including pneumonia as MRDx only likely underestimate hospitalized CAP incidence. The aim of this study was to estimate the burden of hospitalized all-cause CAP in Canada and to assess the contribution of ODx-coded cases to the overall disease burden. This longitudinal retrospective study obtained data from the Canadian Institutes of Health Information (CIHI) for adults 50+ years hospitalized for CAP between 1 April 2009 and 31 March 2019. Cases were identified as those where pneumonia was either diagnosis code type M (MRDx) or pre-admit comorbidity type 1 (ODx). Reported outcomes include pneumonia incidence rate, in-hospital mortality, hospital length of stay, and cost. Outcomes were stratified by age group, case coding, and comorbidity. Between 2009-2010 and 2018-2019, CAP incidence increased from 805.66 to 896.94 per 100,000. During this time, 55-58% of cases had pneumonia coded as ODx. Importantly, these cases had longer hospital stays, higher in-hospital mortality, and higher cost of hospitalization. The burden of CAP remains substantial and is significantly greater than that estimated by solely focusing on MRDx-coded cases. Our findings have implications for policy decision making related to current and future immunization programs.

Indexed as

Canadacommunity-acquired pneumoniacostshospitalizationmost responsible diagnosis (MRDx)other than most responsible diagnosis (ODx)real world

Identifiers

PMID37112660
PMCPMC10146146
OpenAlexW4361192109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.